[go: up one dir, main page]

IL124542A - Method for the preparation of biphenyl isoxazole sulfonamides - Google Patents

Method for the preparation of biphenyl isoxazole sulfonamides

Info

Publication number
IL124542A
IL124542A IL12454297A IL12454297A IL124542A IL 124542 A IL124542 A IL 124542A IL 12454297 A IL12454297 A IL 12454297A IL 12454297 A IL12454297 A IL 12454297A IL 124542 A IL124542 A IL 124542A
Authority
IL
Israel
Prior art keywords
preparation
isoxazole sulfonamides
biphenyl isoxazole
biphenyl
sulfonamides
Prior art date
Application number
IL12454297A
Other languages
English (en)
Other versions
IL124542A0 (en
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/786,523 external-priority patent/US5856507A/en
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of IL124542A0 publication Critical patent/IL124542A0/xx
Publication of IL124542A publication Critical patent/IL124542A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL12454297A 1996-02-20 1997-02-19 Method for the preparation of biphenyl isoxazole sulfonamides IL124542A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1197496P 1996-02-20 1996-02-20
US08/786,523 US5856507A (en) 1997-01-21 1997-01-21 Methods for the preparation of biphenyl isoxazole sulfonamides
PCT/US1997/002917 WO1997029747A1 (en) 1996-02-20 1997-02-19 Methods for the preparation of biphenyl isoxazole sulfonamides

Publications (2)

Publication Number Publication Date
IL124542A0 IL124542A0 (en) 1998-12-06
IL124542A true IL124542A (en) 2003-07-06

Family

ID=26682999

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12454297A IL124542A (en) 1996-02-20 1997-02-19 Method for the preparation of biphenyl isoxazole sulfonamides

Country Status (15)

Country Link
US (1) US6515136B1 (xx)
EP (1) EP0904077A4 (xx)
JP (1) JP2001523218A (xx)
KR (1) KR19990087063A (xx)
CN (1) CN1211183A (xx)
AU (1) AU717230B2 (xx)
BR (1) BR9708151A (xx)
CZ (1) CZ263098A3 (xx)
HU (1) HUP0002351A3 (xx)
IL (1) IL124542A (xx)
NO (1) NO311430B1 (xx)
NZ (1) NZ330464A (xx)
PL (1) PL328571A1 (xx)
SG (3) SG87051A1 (xx)
WO (1) WO1997029747A1 (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5846990A (en) * 1995-07-24 1998-12-08 Bristol-Myers Squibb Co. Substituted biphenyl isoxazole sulfonamides
CN1100047C (zh) * 1998-04-28 2003-01-29 中国人民解放军空军总医院 N3－(5－甲基异噁唑)基－3,4－二羟基肉桂酰胺及其制法
ES2318899T3 (es) 1998-07-06 2009-05-01 Bristol-Myers Squibb Company Bifenil sulfonamidas como antagonistas duales de los receptores de angiotensina y endotelina.
DE19858593A1 (de) 1998-12-18 2000-06-21 Merck Patent Gmbh Sulfonyloxazolamine als therapeutische Wirkstoffe
HK1039778A1 (zh) 1999-03-19 2002-05-10 Bristol-Myers Squibb Company 制造联苯异恶唑基磺胺的方法
US6639082B2 (en) 2000-10-17 2003-10-28 Bristol-Myers Squibb Company Methods for the preparation of biphenyl isoxazole sulfonamides
EP1475103A4 (en) * 2002-01-25 2007-11-07 Taisho Pharmaceutical Co Ltd MEANS FOR THE TREATMENT OF CHRONIC KIDNEY DISEASES
CN114262279B (zh) * 2021-12-30 2022-12-16 上海汇禾医疗科技有限公司 一种x射线可显影分子、栓塞微球及其制备方法

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB804036A (en) 1956-03-02 1958-11-05 Hoffmann La Roche A process for the manufacture of a sulphanilamide of the isoxazole series
US2888455A (en) * 1956-09-04 1959-05-26 Shionogi & Co New sulfonamide and process for producing the same
CH364506A (de) 1956-09-04 1962-09-30 Shionogi & Co Verfahren zur Herstellung des therapeutisch wirksamen 3-Sulfanilamido-5-methyl-isoxazols
DE1059459B (de) 1956-09-04 1959-06-18 Shionogi & Co Verfahren zur Herstellung des therapeutisch wertvollen 3-Sulfanilamido-5-methylisoxazols
GB897440A (en) 1960-02-08 1962-05-30 Shionogi & Co Improvements in or relating to sulfonamides
GB1473433A (xx) 1975-10-09 1977-05-11 Banyu Pharmaceutical Co Ltd Hi
US4415496A (en) * 1981-03-23 1983-11-15 Merck & Co., Inc. Bicyclic lactams
DE3276313D1 (en) 1981-09-24 1987-06-19 Beecham Wuelfing Gmbh & Co Kg Sulphonamides
US4661479A (en) * 1982-02-19 1987-04-28 Merck And Co., Inc. Bicyclic lactams as antihypertensives
EP0194548A3 (de) 1985-03-12 1988-08-17 Dr. Karl Thomae GmbH Neue Sulfonylaminoäthylverbindungen, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
US5464853A (en) 1993-05-20 1995-11-07 Immunopharmaceutics, Inc. N-(5-isoxazolyl)biphenylsulfonamides, N-(3-isoxazolyl)biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
US5594021A (en) 1993-05-20 1997-01-14 Texas Biotechnology Corporation Thienyl-, furyl- and pyrrolyl sulfonamides and derivatives thereof that modulate the activity of endothelin
US5571821A (en) 1993-05-20 1996-11-05 Texas Biotechnology Corporation Sulfonamides and derivatives thereof that modulate the activity of endothelin
US5591761A (en) 1993-05-20 1997-01-07 Texas Biotechnology Corporation Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US5514691A (en) 1993-05-20 1996-05-07 Immunopharmaceutics, Inc. N-(4-halo-isoxazolyl)-sulfonamides and derivatives thereof that modulate the activity of endothelin
CA2005741C (en) 1988-12-26 1998-06-02 Hiroyoshi Hidaka Quinoline sulfonoamino compounds having vessel smooth muscle relaxation activity
US5082838A (en) 1989-06-21 1992-01-21 Takeda Chemical Industries, Ltd. Sulfur-containing fused pyrimidine derivatives, their production and use
DE59107440D1 (de) 1990-02-19 1996-04-04 Ciba Geigy Ag Acylverbindungen
JPH05505822A (ja) 1990-03-30 1993-08-26 メルク・エンド・カムパニー・インコーポレーテツド ピラゾール類、イソキサゾール類及びイソチアゾール置換体
US5236928A (en) 1991-03-19 1993-08-17 Merck & Co., Inc. Imidazole derivatives bearing acidic functional groups at the 5-position, their compositions and methods of use as angiotensin II antagonists
TW270116B (xx) 1991-04-25 1996-02-11 Hoffmann La Roche
RU2086544C1 (ru) 1991-06-13 1997-08-10 Хоффманн-Ля Рош АГ Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина
EP0612244B1 (en) 1991-11-05 2001-09-19 Smithkline Beecham Corporation Endothelin receptor antagonists
SE9103397D0 (sv) 1991-11-18 1991-11-18 Kabi Pharmacia Ab Nya substituerade salicylsyror
US5378715A (en) 1992-02-24 1995-01-03 Bristol-Myers Squibb Co. Sulfonamide endothelin antagonists
TW224462B (xx) 1992-02-24 1994-06-01 Squibb & Sons Inc
TW215434B (xx) 1992-03-07 1993-11-01 Hoechst Ag
US5514696A (en) * 1992-05-06 1996-05-07 Bristol-Myers Squibb Co. Phenyl sulfonamide endothelin antagonists
NZ247440A (en) * 1992-05-06 1995-04-27 Squibb & Sons Inc Phenyl sulphonamide derivatives, preparation and pharmaceutical compositions thereof
AU4376893A (en) 1992-05-19 1993-12-13 Immunopharmaceutics, Inc. Compounds that modulate endothelin activity
TW287160B (xx) 1992-12-10 1996-10-01 Hoffmann La Roche
DK0617001T3 (da) 1993-03-19 2000-04-17 Merck & Co Inc Phenoxyphenyleddikesyrederivater
CA2121724A1 (en) 1993-04-21 1994-10-22 Toshifumi Watanabe Methods and compositions for the prophylactic and/or therapeutic treatment of organ hypofunction
TW394761B (en) 1993-06-28 2000-06-21 Hoffmann La Roche Novel Sulfonylamino Pyrimidines
DE59409631D1 (de) 1993-07-15 2001-02-15 Hoffmann La Roche Pharmazeutische Kombination, die einen Hemmer des Renin-Angiotensin-Systems und einen Endothelin-Antagonisten enthält
US5965732A (en) 1993-08-30 1999-10-12 Bristol-Myers Squibb Co. Sulfonamide endothelin antagonists
GB9504854D0 (en) 1994-03-31 1995-04-26 Zeneca Ltd Nitrogen derivatives
GB9409618D0 (en) 1994-05-13 1994-07-06 Zeneca Ltd Pyridine derivatives
US5612359A (en) * 1994-08-26 1997-03-18 Bristol-Myers Squibb Company Substituted biphenyl isoxazole sulfonamides
IL116916A (en) * 1995-02-06 2000-09-28 Bristol Myers Squibb Co Substituted biphenyl sulfonamide derivatives and pharmaceutical compositions containing the same
DE19509950A1 (de) 1995-03-18 1996-09-19 Merck Patent Gmbh Endothelin-Rezeptor-Antagonisten
ATE243203T1 (de) 1995-04-04 2003-07-15 Texas Biotechnology Corp Thienyl-, furyl-, pyrrolyl- und biphenylsulfonamide und derivate zur modulation der endothelin-aktivität
UA58494C2 (uk) 1995-06-07 2003-08-15 Зенека Лімітед Похідні n-гетероарилпіридинсульфонаміду, фармацевтична композиція, спосіб одержання та спосіб протидії впливам ендотеліну
GB9512697D0 (en) 1995-06-22 1995-08-23 Zeneca Ltd Heterocyclic compounds
US5846990A (en) * 1995-07-24 1998-12-08 Bristol-Myers Squibb Co. Substituted biphenyl isoxazole sulfonamides
US5580894A (en) * 1996-01-11 1996-12-03 Howard University Isoxazolyl enaminones

Also Published As

Publication number Publication date
BR9708151A (pt) 1999-07-27
CZ263098A3 (cs) 1999-05-12
US6515136B1 (en) 2003-02-04
NO983784L (no) 1998-08-19
HUP0002351A2 (hu) 2001-09-28
JP2001523218A (ja) 2001-11-20
SG87051A1 (en) 2002-03-19
NZ330464A (en) 2000-04-28
SG87052A1 (en) 2002-03-19
NO311430B1 (no) 2001-11-26
PL328571A1 (en) 1999-02-01
HUP0002351A3 (en) 2001-10-29
AU1973797A (en) 1997-09-02
NO983784D0 (no) 1998-08-19
IL124542A0 (en) 1998-12-06
AU717230B2 (en) 2000-03-23
SG87053A1 (en) 2002-03-19
CN1211183A (zh) 1999-03-17
EP0904077A4 (en) 1999-12-22
EP0904077A2 (en) 1999-03-31
WO1997029747A1 (en) 1997-08-21
KR19990087063A (ko) 1999-12-15

Similar Documents

Publication Publication Date Title
IL135813A (en) Method for the preparation of citalopram
ZA9711090B (en) Process for the preparation of hydrocarbons.
IL129759A0 (en) Process for the preparation of benzyl-ethers
ZA979602B (en) Method for the preparation of a foodstuff
IL124542A (en) Method for the preparation of biphenyl isoxazole sulfonamides
HUP9903852A3 (en) Process for the preparation of contrast agents
IL128026A0 (en) Process for the preparation of hexanitrohexa-azaisowurtzitanes
EP0669361A3 (en) Process for the preparation of polyheterosiloxanes.
ZA987741B (en) Process for the preparation of oxazaphosphorine-2-amines
GR3036680T3 (en) Process for the preparation of difluoromethane
GR3035436T3 (en) Process for the preparation of 2-H-heptafluoropropane
IL120322A0 (en) Process for the preparation of thifluzamide
HUP0001757A3 (en) Improved process for the preparation of halo-4-phenoxyquinolines
ZA971289B (en) Methods for the preparation of biphenyl isoxazole sulfonamides
EP0831156A4 (en) 3-ALCOXYMETHYLCEPHEMS PREPARATION PROCESS
HK1018004A (en) Methods for the preparation of biphenyl isoxazole sulfonamides
ZA989241B (en) Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides
ZA972099B (en) Process for the preparation of a dessert
GB9805999D0 (en) Method for the preparation of emulsions
IL116759A0 (en) Process for the preparation of para-fluorophenol
HUP0201320A2 (en) Methods for the preparation of biphenyl isoxazole sulfonamides and intermediates thereof
AU2074297A (en) Substituted biphenyl isoxazole sulfonamides
ZA971423B (en) Substituted biphenyl isoxazole sulfonamides
IL132237A (en) Process for the preparation of 3-isochromanone
HK1020006A (en) Substituted biphenyl isoxazole sulfonamides

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees